Biomarker & Intervention Discovery

Anxiety Disorders

Pharmacologically actionable gene targets, therapeutic agents ranked by evidence tier, and active clinical trials.

NIH funding$253MFY2025 · RCDC estimate
Spontaneous remissionGAD: spontaneous remission in ~25-30% at 1 year without treatment; social anxiety: 36% remission at 12 years…
Best-intervention remissionCBT (gold standard): 60-80% treatment response, 40-60% full remission at 12-24 weeks; combination CBT + SSRI superior…
Gap sizeLarge — CBT is consistently superior to medication for long-term outcomes but is massively underused relative to…
Primary barrierpractice/access
Full remission profile →

Remission & chronicity

Spontaneous remission
GAD: spontaneous remission in ~25-30% at 1 year without treatment; social anxiety: 36% remission at 12 years untreated; panic disorder: 50-65% spontaneous partial remission but relapse common; 40-60% remain symptomatic at 5 years
Best-intervention remission
CBT (gold standard): 60-80% treatment response, 40-60% full remission at 12-24 weeks; combination CBT + SSRI superior to either alone in some disorders; exposure therapy for specific phobias: 90%+ response; SSRI/SNRI alone: 50-60% response
Gap size
Large — CBT is consistently superior to medication for long-term outcomes but is massively underused relative to pharmacotherapy
Primary barrier
practice/access
SSRIs/SNRIs are first-line by default in most primary care settings; CBT is guideline-recommended but wait times of 6-18 months are common; digital CBT (iCBT) is evidence-based but rarely prescribed; benzodiazepines continue to be prescribed long-term despite dependence risk
Biomarker Targets & Therapeutic Agents

Gene targets queried against DGIdb, Open Targets, ChEMBL, PubMed, and Europe PMC. Agents ranked: ● Clinical > ● Mechanistic > ● Correlative.

BDNF 126CRH 9GABRA1 303GABRA2 237HTR1A 260SLC6A2 269SLC6A4 224
Therapeutic Agent Effect Direction Evidence Tier Potency Source
TRAMADOL ? unclear Mechanistic
FLUTICASONE activates Mechanistic
IONOMYCIN ? unclear Mechanistic
MONOAMINE OXIDASE INHIBITOR ? unclear Mechanistic
FREUND'S ADJUVANT ? unclear Mechanistic
LITHIUM ? unclear Mechanistic
ZINC SULFATE ANHYDROUS ? unclear Mechanistic
CAPSAICIN ? unclear Mechanistic
PROPRANOLOL HYDROCHLORIDE ? unclear Mechanistic
MARIJUANA ? unclear Mechanistic
NORTRIPTYLINE ? unclear Mechanistic
BORTEZOMIB ? unclear Mechanistic
GLUCAGON (RDNA) ? unclear Mechanistic
COLCHICINE ? unclear Mechanistic
DOXEPIN HYDROCHLORIDE ? unclear Mechanistic
DRONABINOL ? unclear Mechanistic
TANAPROGET activates Mechanistic
CYCLOOXYGENASE INHIBITOR ? unclear Mechanistic
VERTEPORFIN ? unclear Mechanistic
ANTIOXIDANT ? unclear Mechanistic
DITIOCARB ? unclear Mechanistic
APR19 inhibits Mechanistic
DOXORUBICIN HYDROCHLORIDE ? unclear Mechanistic
OPIATE ? unclear Mechanistic
OXIDOPAMINE ? unclear Mechanistic
TETRADECANOYLPHORBOL ACETATE ? unclear Mechanistic
INSULIN, REGULAR, HUMAN ? unclear Mechanistic
PROPYLTHIOURACIL ? unclear Mechanistic
TROGLITAZONE ? unclear Mechanistic
TYROSINE HYDROXYLASE INHIBITOR ? unclear Mechanistic
ALTEPLASE ? unclear Mechanistic
MEDICATION ? unclear Mechanistic
HALOPERIDOL DECANOATE ? unclear Mechanistic
ASOPRISNIL inhibits Mechanistic
ANALGESIC AGENT ? unclear Mechanistic
TCDD ? unclear Mechanistic
THERAPEUTIC GONADOTROPIN ? unclear Mechanistic
METHADONE HYDROCHLORIDE ? unclear Mechanistic
RECOMBINANT TRANSFORMING GROWTH FACTOR ? unclear Mechanistic
ONAPRISTONE inhibits Mechanistic

Showing top 40 of 126 agents ranked by evidence tier.

Therapeutic Agent Effect Direction Evidence Tier Potency Source
ROSIGLITAZONE ? unclear Mechanistic
ACIVICIN inhibits Mechanistic
MEDICATION ? unclear Mechanistic
GGSTOP inhibits Mechanistic
ANTIDEPRESSANT AGENT ? unclear Mechanistic
IRX-2 ? unclear Mechanistic
ANTISERUM ? unclear Mechanistic
NALOXONE HYDROCHLORIDE ? unclear Mechanistic
CHEMBL5286255 inhibits Mechanistic 0.7 nM (Ki)
Therapeutic Agent Effect Direction Evidence Tier Potency Source
CHLORDIAZEPOXIDE ~ modulates Mechanistic
ETIFOXINE inhibits Mechanistic
DIAZEPAM ~ modulates Mechanistic 36.0 nM (Kd)
METHARBITAL ~ modulates Mechanistic
L838417 ~ modulates Mechanistic
GANAXOLONE ~ modulates Mechanistic
THIAMYLAL SODIUM ~ modulates Mechanistic
EVT 201 ? unclear Mechanistic
ADINAZOLAM ? unclear Mechanistic
ZK-93423 ? unclear Mechanistic
AMOBARBITAL ? unclear Mechanistic
ETHCHLORVYNOL ~ modulates Mechanistic
SECOBARBITAL SODIUM ~ modulates Mechanistic
MEPHOBARBITAL ? unclear Mechanistic
ZOLPIDEM TARTRATE ~ modulates Mechanistic
METHAQUALONE ~ modulates Mechanistic
TOPIRAMATE ~ modulates Mechanistic
PAGOCLONE ~ modulates Mechanistic
THIOCOLCHICOSIDE ? unclear Mechanistic
[3H]AZIETOMIDATE ? unclear Mechanistic
PENTOBARBITAL SODIUM ~ modulates Mechanistic
MIDAZOLAM HYDROCHLORIDE ~ modulates Mechanistic
TRIAZOLAM ~ modulates Mechanistic 1.0 nM (Kd)
BARBITURATE ? unclear Mechanistic
LORAZEPAM ~ modulates Mechanistic
BUTOBARBITAL ? unclear Mechanistic
TETRAHYDRODEOXYCORTICOSTERONE ~ modulates Mechanistic
CLOTIAZEPAM ~ modulates Mechanistic
MEPROBAMATE activates Mechanistic
[3H]CGS8216 ~ modulates Mechanistic
PROPOFOL ~ modulates Mechanistic
CLOBAZAM ~ modulates Mechanistic
SEVOFLURANE ~ modulates Mechanistic
METHOXYFLURANE ~ modulates Mechanistic
LOREDIPLON ~ modulates Mechanistic
CIPEPOFOL activates Mechanistic
INDIPLON ~ modulates Mechanistic
PHENOBARBITAL ? unclear Mechanistic
PRAZEPAM ~ modulates Mechanistic
CLORAZEPATE ? unclear Mechanistic

Showing top 40 of 303 agents ranked by evidence tier.

Therapeutic Agent Effect Direction Evidence Tier Potency Source
METHARBITAL ~ modulates Mechanistic
OCINAPLON ? unclear Mechanistic
THIOPENTAL ? unclear Mechanistic
DIAZEPAM ~ modulates Mechanistic 17.0 nM (Ki)
PENTOBARBITAL SODIUM ~ modulates Mechanistic
FLUDIAZEPAM ? unclear Mechanistic
ADINAZOLAM ? unclear Mechanistic
ADIPIPLON activates Mechanistic
TOPIRAMATE ~ modulates Mechanistic
CLORAZEPATE DIPOTASSIUM ~ modulates Mechanistic
ENFLURANE ~ modulates Mechanistic
FLUNITRAZEPAM ~ modulates Mechanistic
ETOMIDATE ~ modulates Mechanistic
BUTOBARBITAL ? unclear Mechanistic
CLONAZEPAM ~ modulates Mechanistic
ESZOPICLONE ~ modulates Mechanistic
PHENOBARBITAL ? unclear Mechanistic
MEPROBAMATE activates Mechanistic
PRIMIDONE ~ modulates Mechanistic
ETIFOXINE inhibits Mechanistic
FLURAZEPAM ? unclear Mechanistic
TEMAZEPAM ~ modulates Mechanistic
ALPRAZOLAM ~ modulates Mechanistic 12.0 nM (EC50)
OXAZEPAM ~ modulates Mechanistic
SECOBARBITAL ? unclear Mechanistic
LORAZEPAM ~ modulates Mechanistic
PRAZEPAM ~ modulates Mechanistic
HALOTHANE ~ modulates Mechanistic
FLUMAZENIL ~ modulates Mechanistic 0.7943 nM (Ki)
BUTABARBITAL SODIUM ~ modulates Mechanistic
ABP-700 activates Mechanistic
GANAXOLONE ~ modulates Mechanistic
SECOBARBITAL SODIUM ~ modulates Mechanistic
HEXOBARBITAL ? unclear Mechanistic
ZOPICLONE ~ modulates Mechanistic
DARIGABAT activates Mechanistic
COCAINE ? unclear Mechanistic
MEPHOBARBITAL ? unclear Mechanistic
TALBUTAL ~ modulates Mechanistic
ACAMPROSATE CALCIUM ~ modulates Mechanistic

Showing top 40 of 237 agents ranked by evidence tier.

Therapeutic Agent Effect Direction Evidence Tier Potency Source
SERTRALINE HYDROCHLORIDE ? unclear Mechanistic
QUETIAPINE FUMARATE ? unclear Mechanistic
FLIBANSERIN ? unclear Mechanistic
SARIZOTAN HYDROCHLORIDE activates Mechanistic
LISURIDE ? unclear Mechanistic 0.4 nM (Ki)
CLOZAPINE ? unclear Mechanistic
BIFEPRUNOX activates Mechanistic
DU 125530 inhibits Mechanistic
ILOPERIDONE ? unclear Mechanistic
XALIPRODEN activates Mechanistic
BUSPIRONE HYDROCHLORIDE activates Mechanistic
ENSACULIN HYDROCHLORIDE ? unclear Mechanistic
VORTIOXETINE HYDROBROMIDE activates Mechanistic
NORTRIPTYLINE ? unclear Mechanistic
ELTOPRAZINE ? unclear Mechanistic
ARIPIPRAZOLE LAUROXIL activates Mechanistic
METHYSERGIDE ? unclear Mechanistic
TRAZODONE ? unclear Mechanistic
PIROMELATINE ? unclear Mechanistic
ULOTARONT activates Mechanistic
MN-305 ? unclear Mechanistic
CLOMIPRAMINE ? unclear Mechanistic
OXYMETAZOLINE HYDROCHLORIDE ? unclear Mechanistic
BUSPIRONE ? unclear Mechanistic 3.1 nM (Ki)
MILNACIPRAN ? unclear Mechanistic
MONOAMINE OXIDASE INHIBITOR ? unclear Mechanistic
TRIMIPRAMINE ? unclear Mechanistic
MIRTAZAPINE ? unclear Mechanistic
GEPIRONE activates Mechanistic
OPC-14523 ? unclear Mechanistic
BREXPIPRAZOLE activates Mechanistic
ALVERINE inhibits Mechanistic
NALUZOTAN activates Mechanistic
PARDOPRUNOX activates Mechanistic
MAZAPERTINE SUCCINATE ? unclear Mechanistic
METHAMPHETAMINE ? unclear Mechanistic
DOXEPIN HYDROCHLORIDE ? unclear Mechanistic
AMISULPRIDE inhibits Mechanistic
DEXFENFLURAMINE HYDROCHLORIDE activates Mechanistic
NARATRIPTAN ? unclear Mechanistic

Showing top 40 of 260 agents ranked by evidence tier.

Therapeutic Agent Effect Direction Evidence Tier Potency Source
TESOFENSINE inhibits Mechanistic
PHENMETRAZINE ? unclear Mechanistic
VENLAFAXINE ? unclear Mechanistic 1060.0 nM (Kd)
SIBUTRAMINE HYDROCHLORIDE inhibits Mechanistic
DEXMETHYLPHENIDATE inhibits Mechanistic
TRIMIPRAMINE ? unclear Mechanistic
CLOMIPRAMINE ? unclear Mechanistic
GUANADREL SULFATE ? unclear Mechanistic
TAPENTADOL HYDROCHLORIDE inhibits Mechanistic
LISDEXAMFETAMINE DIMESYLATE ? unclear Mechanistic
PROTRIPTYLINE ? unclear Mechanistic
DESVENLAFAXINE SUCCINATE inhibits Mechanistic
ATOMOXETINE HYDROCHLORIDE inhibits Mechanistic
IOBENGUANE I-123 ? unclear Mechanistic
SURONACRINE MALEATE ? unclear Mechanistic
REBOXETINE inhibits Mechanistic 1.1 nM (Ki)
BICIFADINE inhibits Mechanistic
DOXEPIN HYDROCHLORIDE inhibits Mechanistic
LIAFENSINE inhibits Mechanistic
ORPHENADRINE HYDROCHLORIDE inhibits Mechanistic
DULOXETINE HYDROCHLORIDE inhibits Mechanistic
DASOTRALINE inhibits Mechanistic
DESIPRAMINE HYDROCHLORIDE inhibits Mechanistic
METHYLPHENIDATE HYDROCHLORIDE inhibits Mechanistic
AMITIFADINE inhibits Mechanistic
NEFAZODONE ? unclear Mechanistic 360.0 nM (Kd)
AMITIFADINE HYDROCHLORIDE ? unclear Mechanistic
DEXTROAMPHETAMINE SULFATE ? unclear Mechanistic
TYROSINE HYDROXYLASE INHIBITOR ? unclear Mechanistic
NORTRIPTYLINE ? unclear Mechanistic 6.3 nM (Ki)
MAPROTILINE HYDROCHLORIDE inhibits Mechanistic
ST. JOHN'S WORT ? unclear Mechanistic
DEXTROAMPHETAMINE SACCHARATE ? unclear Mechanistic
AMOXAPINE inhibits Mechanistic
PHENDIMETRAZINE inhibits Mechanistic
PHENYLPROPANOLAMINE HYDROCHLORIDE ? unclear Mechanistic
BUPROPION HYDROCHLORIDE inhibits Mechanistic
BETHANIDINE ? unclear Mechanistic
TRAMADOL ? unclear Mechanistic
MILNACIPRAN ? unclear Mechanistic

Showing top 40 of 269 agents ranked by evidence tier.

Therapeutic Agent Effect Direction Evidence Tier Potency Source
CENTANAFADINE inhibits Mechanistic
METHAMPHETAMINE inhibits Mechanistic
VENLAFAXINE HYDROCHLORIDE inhibits Mechanistic
LUMATEPERONE inhibits Mechanistic
TIANEPTINE ? unclear Mechanistic
IMIPRAMINE HYDROCHLORIDE inhibits Mechanistic
ONDANSETRON HYDROCHLORIDE ? unclear Mechanistic
PEGINTERFERON ALFA-2B ? unclear Mechanistic
DEXFENFLURAMINE ? unclear Mechanistic
BUPROPION HYDROCHLORIDE ? unclear Mechanistic
CITALOPRAM inhibits Mechanistic 1.6 nM (Ki)
TRIMIPRAMINE ? unclear Mechanistic
VENLAFAXINE ? unclear Mechanistic 8.9 nM (Kd)
DISULFIRAM ? unclear Mechanistic
CHLORPHENTERMINE HYDROCHLORIDE ? unclear Mechanistic
PROTRIPTYLINE ? unclear Mechanistic
MILNACIPRAN HYDROCHLORIDE inhibits Mechanistic
CLOMIPRAMINE ? unclear Mechanistic 70.0 nM (IC50)
NORTRIPTYLINE ? unclear Mechanistic
DAPOXETINE inhibits Mechanistic
AMITRIPTYLINE HYDROCHLORIDE inhibits Mechanistic
TEDATIOXETINE inhibits Mechanistic
TRAZODONE inhibits Mechanistic
SERTRALINE HYDROCHLORIDE inhibits Mechanistic
EVODIAMINE ? unclear Mechanistic
PSEUDOEPHEDRINE ? unclear Mechanistic
FLUOXETINE HYDROCHLORIDE inhibits Mechanistic
SIBUTRAMINE ? unclear Mechanistic
TRAMADOL ? unclear Mechanistic
VORTIOXETINE HYDROBROMIDE inhibits Mechanistic
BL-1021 ? unclear Mechanistic
DOXEPIN HYDROCHLORIDE ? unclear Mechanistic
DOTHIEPIN inhibits Mechanistic
DEXTROMETHORPHAN POLISTIREX ? unclear Mechanistic
DESIPRAMINE ? unclear Mechanistic
PHENTERMINE RESIN ? unclear Mechanistic
NORTRIPTYLINE HYDROCHLORIDE inhibits Mechanistic
MONOAMINE OXIDASE INHIBITOR ? unclear Mechanistic
MILNACIPRAN ? unclear Mechanistic
RIBAVIRIN ? unclear Mechanistic

Showing top 40 of 224 agents ranked by evidence tier.


Clinical Trials

Recruiting and recently completed trials from ClinicalTrials.gov. Data retrieved 2026-07-06.

No recent clinical trials found on ClinicalTrials.gov for this condition.


Agents Found By Disease-Level Search

Searched directly from “Anxiety Disorders” via ClinicalTrials.gov interventions and Open Targets' disease→drug data — independent of the 7-gene target panel above. This surfaces agents whose mechanism doesn't route through a curated gene (combination therapies, standard-of-care drugs, targets outside the panel).

Not yet run. python -m biomarker_pipeline.run_disease_agent_discovery --disease "..."

Part of the Open Source Medicine Foundation Network

Open Source Medicine Foundation The OSMF hub — advancing open-source biomedical research infrastructure, tools, and evidence synthesis.
SpikeProtein.site Database and research resource on SARS-CoV-2 spike protein biology, persistence, and clinical implications.
Vaccine Data Navigator Open-access navigation tool for vaccine adverse event reporting and surveillance data.
PACVS Research Summit Annual summit convening researchers, clinicians, and patients on PACVS science.